AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
171.56
-2.14 (-1.23%)
At close: Jan 17, 2025, 4:00 PM
171.60
+0.04 (0.02%)
After-hours: Jan 17, 2025, 7:12 PM EST
AbbVie Market Cap
AbbVie has a market cap or net worth of $303.17 billion as of January 17, 2025. Its market cap has increased by 7.01% in one year.
Market Cap
303.17B
Enterprise Value
367.21B
1-Year Change
7.01%
Ranking
Category
Stock Price
$171.56
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $303.17B, an increase of 446.36%. That is a compound annual growth rate of 15.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 303.17B | -3.46% |
Dec 31, 2024 | 314.02B | 14.77% |
Dec 29, 2023 | 273.61B | -4.27% |
Dec 30, 2022 | 285.80B | 19.40% |
Dec 31, 2021 | 239.37B | 26.54% |
Dec 31, 2020 | 189.17B | 44.48% |
Dec 31, 2019 | 130.93B | -5.58% |
Dec 31, 2018 | 138.67B | -10.18% |
Dec 29, 2017 | 154.39B | 51.71% |
Dec 30, 2016 | 101.76B | 5.08% |
Dec 31, 2015 | 96.84B | -7.12% |
Dec 31, 2014 | 104.26B | 24.10% |
Dec 31, 2013 | 84.01B | 51.40% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 352.70B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |
AstraZeneca | 206.76B |